NORTHSTAR ASSET MANAGEMENT Co Sells 300 Shares of iShares Biotechnology ETF $IBB

NORTHSTAR ASSET MANAGEMENT Co decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 13.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,875 shares of the financial services provider’s stock after selling 300 shares during the quarter. NORTHSTAR ASSET MANAGEMENT Co’s holdings in iShares Biotechnology ETF were worth $237,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Moors & Cabot Inc. raised its position in shares of iShares Biotechnology ETF by 2.0% in the first quarter. Moors & Cabot Inc. now owns 29,053 shares of the financial services provider’s stock valued at $3,716,000 after purchasing an additional 558 shares during the period. IFP Advisors Inc increased its position in iShares Biotechnology ETF by 23.9% during the first quarter. IFP Advisors Inc now owns 19,849 shares of the financial services provider’s stock worth $2,539,000 after acquiring an additional 3,831 shares during the period. N.E.W. Advisory Services LLC bought a new position in iShares Biotechnology ETF during the first quarter worth $45,000. John G Ullman & Associates Inc. bought a new position in iShares Biotechnology ETF during the first quarter worth $230,000. Finally, KFG Wealth Management LLC increased its position in iShares Biotechnology ETF by 4.8% during the second quarter. KFG Wealth Management LLC now owns 2,444 shares of the financial services provider’s stock worth $309,000 after acquiring an additional 112 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.4%

Shares of IBB stock opened at $155.16 on Friday. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $157.19. The firm’s fifty day simple moving average is $144.88 and its 200 day simple moving average is $132.65.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were given a dividend of $0.0828 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.